A Retrospective Observational Descriptive Study on the Effectiveness and Usage of Emicizumab and Antihemophilic Factor (recombinant), Fc Fusion Protein in Patients with Hemophilia A in the US

被引：0
|
作者：
Cockerham, Alex [1 ]
Wilson, Amanda [2 ]
Frick, Andrew [3 ]
Dasmahapatra, Pronabesh [2 ]
机构：
[1] Sanofi, Brookline, MA USA
[2] Sanofi, Cambridge, MA USA
[3] Trio Hlth, San Diego, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148325
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3031
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [31] Healthcare costs among hemophilia A patients in the United States treated with rurioctocog alfa pegol (FVIII-PEG) or antihemophilic factor (recombinant), FC fusion protein (rFVIIIFc) using real-world data
    Farahbakhshian, Sepehr
    Fan, Qi
    Schultz, Bob G.
    Princic, Nicole
    Park, Julie
    Bullano, Michael
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1278 - 1286
  • [32] Pharmacokinetics Of Recombinant Factor VIII Fc Fusion Protein (rFIIIFc) in Pediatric Subjects With Hemophilia A: An Interim Analysis Of The Kids A-LONG Study
    Young, Guy
    Mahlangu, Johnny
    Nolan, Beatrice
    Brown, Simon
    Valentino, Leonard A.
    Liesner, Raina
    Dong, Yingwen
    Diao, Lei
    Jiang, Haiyan
    Nugent, Karen
    Pierce, Glenn F.
    Allen, Geoffrey
    BLOOD, 2013, 122 (21)
  • [33] Clinical efficacy of recombinant factor VIII Fc fusion protein in hemophilia A patient receiving on demand treatment only, a cross sectional study
    Saad, Saima
    Altaf, Chaudhry
    Ahmed, Pervaiz
    Zafar, Lubna
    Iqbal, Muhammad
    Zafar, Tahira
    HAEMOPHILIA, 2018, 24 : 58 - 58
  • [34] Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
    Shapiro, Amy D.
    Ragni, Margaret V.
    Valentino, Leonard A.
    Key, Nigel S.
    Josephson, Neil C.
    Powel, Jerry S.
    Cheng, Gregory
    Thompson, Arthur R.
    Goyal, Jaya
    Tubridy, Karen L.
    Peters, Robert T.
    Dumont, Jennifer A.
    Euwart, Donald
    Li, Lian
    Hallen, Bengt
    Gozzi, Peter
    Bitonti, Alan J.
    Jiang, Haiyan
    Luk, Alvin
    Pierce, Glenn F.
    BLOOD, 2012, 119 (03) : 666 - 672
  • [35] Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports
    Wang, Michael
    Teresa Alvarez-Roman, Maria
    Chowdary, Pratima
    Quon, Doris V.
    Schafer, Kim
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (07) : 737 - 744
  • [36] Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis
    Carcao, M.
    Shapiro, A.
    Staber, J. M.
    Hwang, N.
    Druzgal, C.
    Lieuw, K.
    Belletrutti, M.
    Thornburg, C. D.
    Ahuja, S. P.
    Morales-Arias, J.
    Dumont, J.
    Miyasato, G.
    Tsao, E.
    Jain, N.
    Pipe, S. W.
    HAEMOPHILIA, 2018, 24 (02) : 245 - 252
  • [37] Longitudinal modified hemophilia joint health scores (mHJHS) outcomes with recombinant factor VIII Fc fusion protein (rFVIIIFc) prophylaxis in subjects with severe hemophilia A
    Oldenburg, Johannes
    Kulkarni, Roshni
    Srivastava, Alok
    Mahlangu, Johnny
    Lethagen, Stefan
    Tsao, Elisa
    Jain, Nisha
    HAEMOPHILIA, 2016, 22 : 40 - 40
  • [38] FINAL DATA FROM THE PREVENT STUDY EVALUATING REAL-WORLD USAGE AND EFFECTIVENESS OF A RECOMBINANT FACTOR VIII FC AND RECOMBINANT FACTOR IX FC IN HAEMOPHILIA A OR B IN GERMANY
    Bidlingmaier, C.
    Heller, C.
    Langer, F.
    Miesbach, W.
    Schotz, U.
    Oldenburg, J.
    Roehss, J.
    Falk, A.
    Santagostino, E.
    Tiede, A.
    HAEMOPHILIA, 2023, 29 : 48 - 49
  • [39] PERIOPERATIVE MANAGEMENT OF PATIENTS WITH SEVERE HAEMOPHILIA A WITH RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC)
    Bocchinfuso, S.
    O'Donovan, M.
    Singleton, E.
    Benson, J.
    Byrne, M.
    Ryan, K.
    O'Donnell, J. S.
    O'Connell, N. M.
    HAEMOPHILIA, 2021, 27 : 105 - 106
  • [40] Clinical Development of Rfviiifc, a Novel, Long-Lasting Recombinant Fc Fusion Replacement Factor, in Patients with Severe Hemophilia A
    Powell, Jerry
    Josephson, Neil
    Perry, David
    Nugent, Karen
    Gor, Dee
    Pestana, Harold
    Franc-Poole, Elke
    Li, Lian
    Greblikas, Feriandas
    Allen, Geoff
    Dabora, Sandra
    Krassova, Snejana
    Luk, Alvin
    Pierce, Glenn
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S176 - S177
12345